Bio Preventive Medicine Corporation (BPM), a leading-edge In Vitro Diagnostics (IVD) company, announced on Aug. 31th, 2020, that their diagnostic kit DNlite-IVD103 has obtained MDA approval in Malaysia and ready to enter ASEAN market.
For those interested in learning more about DNlite-IVD103 in person, BPM will be exhibiting at the EASD 2020 virtual exhibition ( https://www.easd.org/) from September 21st till the 25th at Hall Rome/ No.10